Results 91 to 100 of about 5,165,706 (279)

Fostering Innovation in Philanthropy [PDF]

open access: yes, 2017
Innovation is a buzzword with growing resonance in the philanthropic community. But how are foundations going about adopting innovative practices? In this guide, you'll learn the definition of "innovation"; 8 approaches to philanthropic innovation; key ...

core  

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga   +8 more
wiley   +1 more source

Pricing under innovation [PDF]

open access: yes, 2018
We study pricing when firms introduce process and product innovations over time. We set up a model of endogenous productivity and markup under imperfect competition and dynamic pricing.
Jaumandreu, J., Lin, Shuheng
core  

A bioinformatics screen identifies TCF19 as an aggressiveness‐sustaining gene in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Gene expression meta‐analysis in multiple prostate cancer patient cohorts identifies Transcription factor 19 (TCF19) as an aggressiveness‐sustaining gene with prognostic potential. TCF19 is a gene repressed by androgen signaling that sustains core cancer‐related processes such as vascular permeability or tumor growth and metastasis.
Amaia Ercilla   +15 more
wiley   +1 more source

A study on entrepreneurial innovation among entities in Singapore

open access: yesJournal of Innovation and Entrepreneurship
The present study aimed to study the entrepreneurial innovation among entities in Singapore. It evaluated the various obstacles that affect entrepreneurial innovation within entities. Further, it has also analysed the various elements that are crucial to
Easwaramoorthy Rangaswamy   +3 more
doaj   +1 more source

The Shifting Geography of Innovation in the Era of COVID-19: Exploring Small Business Innovation and Technology Awards in the U.S.

open access: yesUrban Science
This research examines the shifting geography of small firm innovation in the U.S. by tracking the location of small business innovation research (SBIR) and small business technology transfer (STTR) awardees between 2010 and 2024.
Bradley Bereitschaft
doaj   +1 more source

Home - About - Disclaimer - Privacy